TBPH Theravance Biopharma Inc

Theravance Biopharma Inc is a diversified biopharmaceutical company. It is engaged in discovery, research, development and commercialization of human therapeutics.

$11.03  +0.23 (2.13%)
As of 12/02/2022 15:59:58 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  Cayman Islands
IPO date:  05/16/2014
Outstanding shares:  67,365,912
Average volume:  1,055,322
Market cap:   $727,551,850
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BMNDK09
Valuation   (See tab for details)
PE ratio:   -5.10
PB ratio:   -4.55
PS ratio:   13.41
Return on equity:   41.46%
Net income %:   -268.57%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy